Literature DB >> 1711917

Proteolytic balance and capillary morphogenesis.

M S Pepper1, R Montesano.   

Abstract

Angiogenesis is the process by which new capillary blood vessels are formed from preexisting vessels. A number of components of this morphogenetic process, including endothelial cell invasion and capillary lumen formation, are believed to be dependent on tightly controlled proteolytic degradation of the extracellular matrix. The critical importance of an appropriate balance between proteases and protease inhibitors in these processes is suggested by two sets of observations. Firstly, that extracellular matrix invasion and capillary lumen formation are inhibited in the presence of an excess of protease inhibitors. Secondly, that when unchecked by protease inhibitors, excessive proteolysis is incompatible with normal capillary morphogenesis. These results clearly suggest that a precisely regulated proteolytic balance is necessary for normal capillary morphogenesis.

Mesh:

Substances:

Year:  1990        PMID: 1711917     DOI: 10.1016/0922-3371(90)90046-y

Source DB:  PubMed          Journal:  Cell Differ Dev        ISSN: 0922-3371


  28 in total

Review 1.  Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitors.

Authors:  H Malonne; I Langer; R Kiss; G Atassi
Journal:  Clin Exp Metastasis       Date:  1999-02       Impact factor: 5.150

2.  In vitro and in vivo endochondral bone formation models allow identification of anti-angiogenic compounds.

Authors:  Gabri van der Pluijm; Martine Deckers; Bianca Sijmons; Henny de Groot; John Bird; Ruth Wills; Socrates Papapoulos; Andy Baxter; Clemens Löwik
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

Review 3.  Mathematical modeling of tumor-induced angiogenesis.

Authors:  Nikos V Mantzaris; Steve Webb; Hans G Othmer
Journal:  J Math Biol       Date:  2004-02-06       Impact factor: 2.259

Review 4.  The plasminogen activator/plasmin system.

Authors:  J D Vassalli; A P Sappino; D Belin
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

5.  An in vitro three-dimensional coculture model of cerebral microvascular angiogenesis and differentiation.

Authors:  L R Ment; W B Stewart; D Scaramuzzino; J A Madri
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-10       Impact factor: 2.416

Review 6.  Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy.

Authors:  S B Fox; A L Harris
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

7.  Expression of SPARC during development of the chicken chorioallantoic membrane: evidence for regulated proteolysis in vivo.

Authors:  M L Iruela-Arispe; T F Lane; D Redmond; M Reilly; R P Bolender; T J Kavanagh; E H Sage
Journal:  Mol Biol Cell       Date:  1995-03       Impact factor: 4.138

Review 8.  Emerging Histopathological and Genetic Parameters of Pituitary Adenomas: Clinical Impact and Recommendation for Future WHO Classification.

Authors:  W Saeger; S Petersenn; C Schöfl; U J Knappe; M Theodoropoulou; R Buslei; J Honegger
Journal:  Endocr Pathol       Date:  2016-06       Impact factor: 3.943

9.  Methoxychlor-induced alterations in the histological expression of angiogenic factors in pituitary and uterus.

Authors:  Jerome M Goldman; Ashley S Murr; Angela R Buckalew; Judith E Schmid; Barbara D Abbott
Journal:  J Mol Histol       Date:  2004-05       Impact factor: 2.611

10.  Genistein, a dietary-derived inhibitor of in vitro angiogenesis.

Authors:  T Fotsis; M Pepper; H Adlercreutz; G Fleischmann; T Hase; R Montesano; L Schweigerer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.